Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

MLA

Kamat, Ashish M., et al. “Considerations on the Use of Urine Markers in the Management of Patients with High-Grade Non-Muscle-Invasive Bladder Cancer.” Urologic Oncology, vol. 32, no. 7, Oct. 2014, pp. 1069–77. EBSCOhost, https://doi.org/10.1016/j.urolonc.2014.06.017.

APA

Kamat, A. M., Vlahou, A., Taylor, J. A., Hudson, M. L. A., Pesch, B., Ingersoll, M. A., Todenhöfer, T., van Rhijn, B., Kassouf, W., Barton Grossman, H., Behrens, T., Chandra, A., Goebell, P. J., Palou, J., Sanchez-Carbayo, M., & Schmitz-Dräger, B. J. (2014). Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer. Urologic Oncology, 32(7), 1069–1077. https://doi.org/10.1016/j.urolonc.2014.06.017

Chicago

Kamat, Ashish M, Antonia Vlahou, John A Taylor, M’ Liss A Hudson, Beate Pesch, Molly A Ingersoll, Tilmann Todenhöfer, et al. 2014. “Considerations on the Use of Urine Markers in the Management of Patients with High-Grade Non-Muscle-Invasive Bladder Cancer.” Urologic Oncology 32 (7): 1069–77. doi:10.1016/j.urolonc.2014.06.017.